IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $599,000 | -78.8% | 10,595 | -82.2% | 0.06% | +106.7% |
Q3 2020 | $2,830,000 | -87.0% | 59,663 | -83.8% | 0.03% | -84.9% |
Q2 2020 | $21,778,000 | +1348.0% | 369,381 | +1060.4% | 0.20% | +1321.4% |
Q1 2020 | $1,504,000 | -18.3% | 31,831 | +3.5% | 0.01% | +27.3% |
Q3 2019 | $1,842,000 | -62.2% | 30,748 | -59.4% | 0.01% | -56.0% |
Q2 2019 | $4,873,000 | – | 75,817 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |